Objectives: This study aimed to determine the effect of concomitant antimicrobial photodynamic therapy (aPTD) on periodontal disease and glycaemic control in patients with type 2 diabetes mellitus (T2DM). Clinical Relevance: aPTD is a noninvasive adjunctive therapy that can positively influence the periodontal treatment outcome.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Probing pocket depth (PPD)
Timeframe: At baseline
Probing pocket depth (PPD)
Timeframe: 90 days after treatment
Bleeding on probing (BOP)
Timeframe: At baseline
Bleeding on probing (BOP)
Timeframe: 90 days after treatment
Clinical attachment level (CAL)
Timeframe: At baseline
Clinical attachment level (CAL)
Timeframe: 90 days after treatment
The presence of five periodontal pathogens, Aggregatibacter actinomycetemcomitans (AA), Porphyromonas gingivalis (PG), Prevotella intermedia (PI), Tanerella forsythia (TF) and Treponema denticola (TD),
Timeframe: At baseline
The presence of five periodontal pathogens, Aggregatibacter actinomycetemcomitans (AA), Porphyromonas gingivalis (PG), Prevotella intermedia (PI), Tanerella forsythia (TF) and Treponema denticola (TD),
Timeframe: 90 days after treatment
HbA1c test
Timeframe: At baseline
HbA1c test
Timeframe: 90 days after treatment